LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
105.80
+5.10 (5.06%)
Sep 30, 2026, 4:08 PM HKT

LongBio Pharma (Suzhou) Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-216.18-175.58-137.32-95.78
Depreciation & Amortization
8.097.67.255.61
Loss (Gain) From Sale of Assets
0.020.07--
Loss (Gain) From Sale of Investments
-1.3-1.24-0.5-
Stock-Based Compensation
9.588.840.731.49
Other Operating Activities
4.1817.6630.816.54
Change in Accounts Payable
42.5418.336.767.52
Change in Unearned Revenue
-0.85-1.092.410.96
Change in Other Net Operating Assets
-13.234.38-14.262.81
Operating Cash Flow
-167.16-121.04-104.12-60.87
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-3.88-4.39-6.15-2.47
Investment in Securities
-163.43-53.87-39.6-
Other Investing Activities
1.041.120.19-
Investing Cash Flow
-166.26-57.14-45.56-2.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Short-Term Debt Issued
-48.2537.8813
Long-Term Debt Issued
--20-
Total Debt Issued
67.648.2557.8813
Short-Term Debt Repaid
--51.13-13-
Long-Term Debt Repaid
--24.99-4.31-2.05
Lease Payments
-4.37-4.31-4.31-2.05
Total Debt Repaid
-81.18-76.12-17.31-2.05
Net Debt Issued (Repaid)
-13.58-27.8740.5710.95
Issuance of Common Stock
1,186263.7760112.2
Other Financing Activities
-67.64-27.38-1.46-0
Financing Cash Flow
1,105208.5399.11123.14

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Foreign Exchange Rate Adjustments
-4-1.92-0.040.02
Net Cash Flow
767.6528.43-50.659.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-171.04-125.43-110.27-63.34
Free Cash Flow Growth
----
Free Cash Flow Per Share
-2.77-2.21-2.32-1.48
Levered Free Cash Flow
--79.09-87.48-
Unlevered Free Cash Flow
--68.55-68.11-
Free Cash Flow After Leases
-175.41-129.73-114.58-65.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
1.020.980.810
Cash Income Tax Paid
--0.04-
Change in Working Capital
28.4621.62-5.0811.28